Clinical Trial Update: Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating afatinib for non-small-cell lung cancer, reporting efficacy and safety in completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Carcinoma

Drugs mentioned

• Afatinib (afatinib)

Snippet

Sponsor: University College, London | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED